Members of the FDA's Patient Engagement Advisory Committee shared their concerns about augmented reality and virtual reality health care devices at the second day of a PEAC meeting on the topic held Wednesday (July 13), asking how reliable information about the technologies would reach patients and caregivers and what role FDA might play.[Inside Telehealth 7.14.2022]

Sign up and receive this full article here> https://insidehealthpolicy.com/inside-telehealth-daily-news/fda-advisers-how-do-patients-get-virtual-reality-device-risk-efficacy. 

###